Insulet (PODD) ebitda was $627M in FY2025 (+37% YoY). The tables below show the complete quarterly and annual ebitda history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual EBITDA
Fiscal Year
EBITDA
YoY
2025
$627M
+37%
2024
$459M
+34%
2023
$341M
+141%
2022
$142M
-35%
2021
$218M
+53%
2020
$143M
+34%
2019
$107M
+31%
2018
$82M
+112%
2017
$38M
+43%
2016
$27M
+290%
2015
-$14M
-156%
2014
$25M
+648%
2013
-$5M
+69%
2012
-$15M
+43%
2011
-$26M
+8%
2010
-$29M
+43%
2009
-$50M
Recent Quarterly EBITDA
Quarter
EBITDA
Q2 2026
$176M
Q1 2026
$170M
Q4 2025
$230M
Q3 2025
$137M
Q2 2025
$131M
Q1 2025
$129M
Q4 2024
$186M
Q3 2024
$109M
Q2 2024
$74M
Q1 2024
$90M
Q4 2023
$170M
Q3 2023
$68M
Source: PODD on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.